Aclaris Therapeutics, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-13 | NCT07935590 Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen… | Phase 2 | Recruiting |
Active trials by phase
| Phase 2 | 2 |
Disease areas by active trials
Get alerts when Aclaris Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.